Influence of MSI and 18q LOH markers on capecitabine adjuvant monotherapy in colon cancer patients

PURPOSE: The aim of this study was to evaluate whether pretreatment analysis of selected molecular markers can be used for the prediction of disease-free survival (DFS)/overall survival (OS) of capecitabine adjuvant monotherapy in colon cancer patients. PATIENTS AND METHODS: A total of 126 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Matevska-Geshkovska, Nadica, Staninova-Stojovska, Marija, Kapedanovska-Nestorovska, Aleksandra, Petrushevska-Angelovska, Natalija, Panovski, Milco, Grozdanovska, Biljana, Mitreski, Nenad, Dimovski, Aleksandar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219100/
https://www.ncbi.nlm.nih.gov/pubmed/30464574
http://dx.doi.org/10.2147/PGPM.S172467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219100/
https://www.ncbi.nlm.nih.gov/pubmed/30464574
http://dx.doi.org/10.2147/PGPM.S172467

Ejemplares similares